Risks to the Returns to Medical Innovation: The Case of Myriad Genetics

30 Pages Posted: 18 Aug 2015 Last revised: 1 Mar 2023

See all articles by Jeffrey P. Clemens

Jeffrey P. Clemens

University of California, San Diego (UCSD) - Department of Economics; NBER

Stan Veuger

American Enterprise Institute

Date Written: August 2015

Abstract

We describe the broad range of uncertainties faced by the developers of medical technologies. Empirically, we estimate the asset market incidence of two realizations of uncertainties we classify as within-market policy risks. The events we analyze concern the intellectual property of Myriad Genetics, Inc., an American molecular diagnostics firm. In June 2013, the Supreme Court invalidated several of Myriad's intellectual property claims. Subsequently, the Center for Medicare and Medicaid Services (CMS) re-evaluated the reimbursements it pays for the services at issue in the Supreme Court's ruling. Each of these events moved Myriad's market capitalization by several hundred million dollars, or on the order of 20 percent. Myriad's exposure to the realization of these events reflected the concentration of its revenue streams among the affected services. We discuss the implications of the risks we analyze for the total volume of medical innovation and for its organization across firms.

Suggested Citation

Clemens, Jeffrey P. and Veuger, Stan, Risks to the Returns to Medical Innovation: The Case of Myriad Genetics (August 2015). NBER Working Paper No. w21469, Available at SSRN: https://ssrn.com/abstract=2645565

Jeffrey P. Clemens (Contact Author)

University of California, San Diego (UCSD) - Department of Economics ( email )

9500 Gilman Drive
La Jolla, CA 92093-0508
United States

HOME PAGE: http://econweb.ucsd.edu/~j1clemens/

NBER ( email )

1050 Massachusetts Avenue
Cambridge, MA 02138
United States

Stan Veuger

American Enterprise Institute ( email )

1789 Massachusetts Ave NW
Washington, DC 20036
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
27
Abstract Views
495
PlumX Metrics